Evidence map›Paper›PMID 41836062›Full record

ArticleBMC methods2026

A methodological framework for constructing opioid agonist therapy episodes in administrative health data.

Kiana Yazdani, Cassidy Tam, Christopher C Fisher, Scott D Emerson, Jason Trigg, Katherine W Kooij, Mary A De Vera, Fidel Vila-Rodriguez, Robert S Hogg, Julio S G Montaner and 1 more

Abstract read
In one paragraph

Article in BMC methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kiana YazdaniEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Cassidy TamEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Christopher C FisherEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Scott D EmersonEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Jason TriggEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Katherine W KooijEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Mary A De VeraThe University of British Columbia, Vancouver, BC Canada.
Fidel Vila-RodriguezThe University of British Columbia, Vancouver, BC Canada.
Robert S HoggEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Julio S G MontanerEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Viviane Dias LimaEpidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Opioid Agonist Therapy (OAT) is the most effective intervention to reduce overdose risk, and administrative health data are now increasingly used to study OAT outcomes. However, current methods for constructing OAT episodes rely heavily on fixed permissible gaps and often overlook switches between medications, concurrent therapies, and the temporal complexity of dispensing patterns. We aimed to develop a robust episode-construction framework that more precisely reflects real-world OAT use within administrative health data. Methods: We analyzed OAT dispensations from people living with HIV in British Columbia (2010-2020). Episodes were constructed using three components: Allen's interval algebra, temporal margins ([Formula: see text]), and drug-specific permissible gaps. Allen's algebra characterized the temporal relation between two dispensations as Results: The Conclusion: We propose an episode-building framework based on Allen's relations, temporal margins, and permissible gaps that fine-tune OAT classification in administrative health data. The method is transferable to other settings and populations with suitable parameter adjustments. Supplementary Information: The online version contains supplementary material available at 10.1186/s44330-026-00064-9.

Indexed as

Administrative health dataAllen’s relationsMedication episode constructionOpioid agonist therapyOpioid use disorderPermissible gapTemporal margin

Identifiers

PMID41836062
PMCPMC12979340

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.